benzotriazole has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chigurupati, S; Hameed, S; Khan, KM; Rafique, R; Rehman, AU; Salar, U; Seraj, F; Taha, M; Venugopal, V; Wadood, A | 1 |
| Bahekar, R; Bandyopadhyay, D; Darji, B; Jadav, P; Jain, M; Joharapurkar, A; Kshirsagar, S; Patel, D; Patel, H; Patel, P; Sairam, KV; Shah, SR; Shaikh, M; Siriki, Y | 1 |
2 other study(ies) available for benzotriazole and Diabetes Mellitus
| Article | Year |
|---|---|
Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies.
Topics: alpha-Amylases; alpha-Glucosidases; Diabetes Mellitus; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Targeted Therapy; Structure-Activity Relationship; Triazoles | 2019 |
Discovery of orally active, potent, and selective benzotriazole-based PTP1B inhibitors.
Topics: Administration, Oral; Animals; Diabetes Mellitus; Enzyme Inhibitors; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Protein Binding; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2011 |